Finecare Carcinoembryonic Antigen (CEA) Rapid Quantitative Test Kit – 25 Tests

The Finecare CEA Rapid Quantitative Test is a fluorescence immunoassay used with the Finecare FIA system for quantitative determination of Carcinoembryonic Antigen (CEA) in human whole blood, serum, or plasma. CEA is a tumor-associated biomarker commonly used as an aid in monitoring treatment response, prognosis, and recurrence in patients with carcinoma. The test is intended for professional in-vitro diagnostic use and should be interpreted alongside other clinical findings rather than as a standalone cancer diagnosis. The Finecare CEA assay provides quantitative results in approximately 15 minutes, making it suitable for hospital laboratories, oncology units, diagnostic centres, and point-of-care testing environments. Key Features - Quantitative CEA measurement - Finecare catalog number W226 - Fluorescence immunoassay technology - Suitable for whole blood, serum, and plasma - 75 µL sample volume - 15-minute reaction time - Measuring range: 1–500 ng/mL - 25 tests per kit - Designed for tumor-marker testing - Useful for treatment monitoring and recurrence follow-up - Professional in-vitro diagnostic use - CE and NMPA listed in Finecare documentation